224 related articles for article (PubMed ID: 26493087)
1. Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.
Chen Y; Xu SC; Duan RD
Lipids Health Dis; 2015 Oct; 14():130. PubMed ID: 26493087
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid inhibits acid sphingomyelinase in intestinal cells.
Zhang P; Cheng Y; Duan RD
Phytother Res; 2013 Feb; 27(2):173-8. PubMed ID: 22511398
[TBL] [Abstract][Full Text] [Related]
3. Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells.
Wu J; Cheng Y; Jönsson BA; Nilsson A; Duan RD
J Lipid Res; 2005 Sep; 46(9):1944-52. PubMed ID: 15961787
[TBL] [Abstract][Full Text] [Related]
4. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells.
Wu J; Cheng Y; Nilsson A; Duan RD
Carcinogenesis; 2004 Aug; 25(8):1327-33. PubMed ID: 15016655
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.
Cheng Y; Liu F; Wu J; Zhang Y; Nilsson A; Duan RD
Lipids; 2009 Oct; 44(10):897-906. PubMed ID: 19777283
[TBL] [Abstract][Full Text] [Related]
6. Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice.
Zhang P; Li B; Gao S; Duan RD
Anticancer Res; 2008; 28(6A):3631-5. PubMed ID: 19189644
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.
Liu F; Cheng Y; Wu J; Tauschel HD; Duan RD
Cancer Lett; 2006 Apr; 235(1):141-6. PubMed ID: 16290921
[TBL] [Abstract][Full Text] [Related]
8. Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.
Feng D; Ohlsson L; Ling W; Nilsson A; Duan RD
Dig Dis Sci; 2010 Dec; 55(12):3377-83. PubMed ID: 20393874
[TBL] [Abstract][Full Text] [Related]
9. Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell cultures.
Gupta AK; Rudney H
J Lipid Res; 1991 Jan; 32(1):125-36. PubMed ID: 2010684
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase.
Liu JJ; Nilsson A; Duan RD
Lipids; 2002 May; 37(5):469-74. PubMed ID: 12056588
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
Zager RA; Burkhart KM; Johnson A
J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
[TBL] [Abstract][Full Text] [Related]
12. Neutral sphingomyelinase.
Chatterjee S
Adv Lipid Res; 1993; 26():25-48. PubMed ID: 8379453
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta stimulates sphingomyelin hydrolysis in cultured granulosa cells: evidence for a regulatory role of ceramide on progesterone and prostaglandin biosynthesis.
Santana P; Llanes L; Hernandez I; Gonzalez-Robayna I; Tabraue C; Gonzalez-Reyes J; Quintana J; Estevez F; Ruiz de Galarreta CM; Fanjul LF
Endocrinology; 1996 Jun; 137(6):2480-9. PubMed ID: 8641202
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity.
Wu J; Liu F; Nilsson A; Duan RD
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G967-73. PubMed ID: 15205117
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis and intracellular processing of BODIPY-sphingomyelin by murine CATH.a neurons.
Nusshold C; Uellen A; Bernhart E; Hammer A; Damm S; Wintersperger A; Reicher H; Hermetter A; Malle E; Sattler W
Biochim Biophys Acta; 2013 Dec; 1831(12):1665-78. PubMed ID: 23973266
[TBL] [Abstract][Full Text] [Related]
16. Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells.
Cheng Y; Kozubek A; Ohlsson L; Sternby B; Duan RD
Planta Med; 2007 Jul; 73(8):725-30. PubMed ID: 17583825
[TBL] [Abstract][Full Text] [Related]
17. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.
Mori K; Stone S; Braverman LE; DeVito WJ
Endocrinology; 1996 Nov; 137(11):4994-9. PubMed ID: 8895373
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
[TBL] [Abstract][Full Text] [Related]
19. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
20. Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2.
Oninla VO; Breiden B; Babalola JO; Sandhoff K
J Lipid Res; 2014 Dec; 55(12):2606-19. PubMed ID: 25339683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
